PL216193B1 - Wyizolowana, ssacza, pochodząca ze szpiku kostnego linia populacji niezróżnicowanych krwiotwórczych komórek macierzystych - Google Patents

Wyizolowana, ssacza, pochodząca ze szpiku kostnego linia populacji niezróżnicowanych krwiotwórczych komórek macierzystych

Info

Publication number
PL216193B1
PL216193B1 PL374868A PL37486803A PL216193B1 PL 216193 B1 PL216193 B1 PL 216193B1 PL 374868 A PL374868 A PL 374868A PL 37486803 A PL37486803 A PL 37486803A PL 216193 B1 PL216193 B1 PL 216193B1
Authority
PL
Poland
Prior art keywords
cells
lin
stem cells
isolated population
hsc
Prior art date
Application number
PL374868A
Other languages
English (en)
Polish (pl)
Other versions
PL374868A1 (en
Inventor
Martin Friedlander
Atsushi Otani
Karen Dasilva
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of PL374868A1 publication Critical patent/PL374868A1/xx
Publication of PL216193B1 publication Critical patent/PL216193B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL374868A 2002-07-25 2003-07-25 Wyizolowana, ssacza, pochodząca ze szpiku kostnego linia populacji niezróżnicowanych krwiotwórczych komórek macierzystych PL216193B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39852202P 2002-07-25 2002-07-25
US46705103P 2003-05-02 2003-05-02

Publications (2)

Publication Number Publication Date
PL374868A1 PL374868A1 (en) 2005-11-14
PL216193B1 true PL216193B1 (pl) 2014-03-31

Family

ID=31191212

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374868A PL216193B1 (pl) 2002-07-25 2003-07-25 Wyizolowana, ssacza, pochodząca ze szpiku kostnego linia populacji niezróżnicowanych krwiotwórczych komórek macierzystych

Country Status (17)

Country Link
US (2) US7153501B2 (enExample)
EP (1) EP1542536B1 (enExample)
JP (2) JP2005538742A (enExample)
KR (2) KR101095287B1 (enExample)
CN (1) CN1307300C (enExample)
AT (1) ATE536405T1 (enExample)
AU (1) AU2003259687B2 (enExample)
BR (1) BR0312920A (enExample)
CA (1) CA2493122C (enExample)
DK (1) DK1542536T3 (enExample)
ES (1) ES2376866T3 (enExample)
MX (1) MXPA05000972A (enExample)
PL (1) PL216193B1 (enExample)
PT (1) PT1542536E (enExample)
RU (1) RU2331669C2 (enExample)
WO (2) WO2004010959A2 (enExample)
ZA (1) ZA200500682B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006031467A2 (en) * 2002-07-25 2006-03-23 The Scripps Research Institute Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
US20060104963A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
US20060104962A1 (en) * 2002-07-25 2006-05-18 The Scripps Research Institute Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
CA2524063C (en) * 2003-05-02 2015-02-17 The Scripps Research Institute Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
US8088585B2 (en) * 2003-10-31 2012-01-03 Children's Medical Center Corporation Methods for purifying hematopoietic stem cells
RU2279886C2 (ru) * 2004-06-10 2006-07-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Минздрава РФ Способ улучшения функциональной активности сетчатки при ее патологии различного генеза
US8282921B2 (en) 2004-08-02 2012-10-09 Paul Glidden tRNA synthetase fragments
JP2008509678A (ja) * 2004-08-13 2008-04-03 メドトロニック・インコーポレーテッド 内皮前駆細胞サブセットの単離とそれらの使用方法
EP1802199A4 (en) * 2004-09-03 2008-08-27 Scripps Research Inst HEMATOPOIETIC STEM CELLS OF ISOLATED NEGATIVE LINES AND METHODS OF TREATMENT THEREOF
DE102004055615A1 (de) * 2004-11-16 2006-05-18 Universitätsklinikum Hamburg-Eppendorf In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung
US20080193435A1 (en) * 2005-02-24 2008-08-14 Martin Friedlander Revascularization of Ischemic Retinal Tissue and Screening Method Therefor
RU2403906C2 (ru) * 2005-02-24 2010-11-20 Дзе Скриппс Рисерч Инститьют Способ лечения ретинопатии при недоношенности и родственных ретинопатических заболеваний
RU2418856C2 (ru) * 2005-02-24 2011-05-20 Дзе Скриппс Рисерч Инститьют Изолированные популяции миелоидоподобных клеток костного мозга и способы лечения с ними
US20070231306A1 (en) * 2005-02-24 2007-10-04 The Scripps Research Institute Isolated myeloid-like cell populations and methods of treatment therewith
JP4734636B2 (ja) * 2005-11-02 2011-07-27 国立大学法人 鹿児島大学 免疫染色法、及び当該免疫染色法を利用した細胞の評価方法
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
WO2007055905A2 (en) 2005-11-07 2007-05-18 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
GEP20135796B (en) 2006-03-07 2013-04-10 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
KR100757265B1 (ko) * 2006-04-27 2007-09-10 (주) 차바이오텍 제대혈 유래 줄기 세포를 포함하는 요실금 치료용 조성물
AU2007272313B2 (en) * 2006-07-12 2013-11-21 Mesoblast, Inc. Treatment of excessive neovascularization
CN101583367B (zh) * 2006-11-07 2013-05-01 夏尔再生医学公司 用于治疗和控制血管生成介导的疾病的材料和方法
US20100098675A1 (en) * 2008-05-30 2010-04-22 Nikolai Tankovich Methods for reducing the side effects of ophthalmic laser surgery
CA2737193A1 (en) * 2008-09-12 2010-03-18 Universidade Federal De Sao Paulo - Unifesp Ischemic tissue cell therapy
BRPI0920976A2 (pt) 2008-12-03 2015-08-18 Amorcyte Inc Composições que melhoram a perfusão da area de infarto e metodos de restauração da lesão vascular.
RU2428956C2 (ru) * 2009-07-13 2011-09-20 Александр Дмитриевич Ромащенко Способ лечения атрофии зрительного нерва посредством трансплантации аутологичных стволовых клеток
WO2012005763A1 (en) 2010-07-06 2012-01-12 The Scripps Research Institute Use of myeloid-like progenitor cell populations to treat tumors
CN110777124A (zh) 2011-10-27 2020-02-11 威尔斯达眼科制剂公司 编码视杆细胞来源的视锥细胞活力因子的载体
WO2013158258A1 (en) * 2012-04-16 2013-10-24 The Regents Of The University Of California Ocular therapeutics using embryonic system cell microvesicles
US11033586B2 (en) 2012-08-24 2021-06-15 Riken Method for producing retinal pigment epithelial cell sheet
CN113498347B (zh) * 2019-02-28 2024-02-02 深圳大学 内皮祖细胞(epc)在治疗早衰综合症疾病的用途
CN121550400B (zh) * 2026-01-26 2026-05-19 天津医科大学眼科医院 Crybb2重组蛋白在治疗和/或预防糖尿病性视网膜病变中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27055C2 (uk) * 1993-12-14 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
US6908763B1 (en) * 1997-08-22 2005-06-21 The Board Of Trustees Of The Leland Stanford Junior University Mammalian common lymphoid progenitor cell
WO1999055837A2 (en) * 1998-04-28 1999-11-04 Nycomed Imaging As Improvements in or relating to separation processes
US6767737B1 (en) * 1998-08-31 2004-07-27 New York University Stem cells bearing an FGF receptor on the cell surface
US6780627B1 (en) * 2000-01-31 2004-08-24 Millennium Pharmaceuticals, Inc. 22438, 23553, 25278, and 26212 novel human sulfatases
WO2002009650A2 (en) * 2000-07-31 2002-02-07 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
CN100486992C (zh) * 2001-02-23 2009-05-13 斯克里普斯研究学院 用于调节血管发生的色氨酰-tRNA合成酶衍生的多肽
WO2003080116A1 (en) * 2002-03-21 2003-10-02 University Of Florida Modulating angiogenesis
WO2004005531A2 (en) * 2002-07-05 2004-01-15 Roger Williams Medical Center Targeting and tracking of cells to specific organs and tissues in vivo

Also Published As

Publication number Publication date
EP1542536A2 (en) 2005-06-22
MXPA05000972A (es) 2005-09-12
AU2003259687A1 (en) 2004-02-16
JP2010285434A (ja) 2010-12-24
PL374868A1 (en) 2005-11-14
KR101095287B1 (ko) 2011-12-16
DK1542536T3 (da) 2012-01-23
RU2331669C2 (ru) 2008-08-20
PT1542536E (pt) 2012-02-14
CA2493122A1 (en) 2004-02-05
BR0312920A (pt) 2007-07-10
JP5385219B2 (ja) 2014-01-08
RU2005105065A (ru) 2005-09-10
WO2004010959A3 (en) 2005-04-07
CN1688196A (zh) 2005-10-26
US7153501B2 (en) 2006-12-26
WO2004098499A2 (en) 2004-11-18
US20040197902A1 (en) 2004-10-07
WO2004098499A3 (en) 2005-10-06
CA2493122C (en) 2012-11-27
JP2005538742A (ja) 2005-12-22
ATE536405T1 (de) 2011-12-15
KR20050027132A (ko) 2005-03-17
ES2376866T3 (es) 2012-03-20
CN1307300C (zh) 2007-03-28
EP1542536A4 (en) 2007-05-16
WO2004010959A2 (en) 2004-02-05
KR20110102961A (ko) 2011-09-19
AU2003259687B2 (en) 2009-10-29
ZA200500682B (en) 2006-07-26
EP1542536B1 (en) 2011-12-07
US20070116685A1 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
CN1307300C (zh) 造血干细胞和治疗新生血管性眼部疾病的方法
KR100869914B1 (ko) 혈관 형성 조절에 유용한 트립토파닐-ｔＲＮＡ 신세타제기원 폴리펩타이드
CN101594781A (zh) 分离的髓样细胞群及其治疗方法
IL195854A (en) Aminoacyl polypeptides - trna human synthesis used to regulate angiogenesis
US20020182666A1 (en) Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
US20040152079A1 (en) Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
PT1935976E (pt) Células do tipo mielóide transfectadas para o tratamento de retinopatia da prematuridade e doenças relacionadas
KR101169261B1 (ko) 조혈 줄기세포 및 이를 포함하는 약제학적 조성물
US6387664B1 (en) Sparc fusion protein and method for producing the same
CN107206096B (zh) 碳硅烷树枝状体及用于药物递送系统的使用该树枝状体获得的可聚集载体
KR101309500B1 (ko) 분리된 계통 음성 조혈 줄기세포 및 이를 사용한 치료 방법
KR100902634B1 (ko) 재조합 ｈｍｇｂ1 펩티드를 포함하는 핵산 전달 복합체
JP3012930B1 (ja) Ｓｐａｒｃ融合タンパク質含有医薬組成物
CN115232813A (zh) 用于构建vWF基因突变的血管性血友病模型猪核移植供体细胞的基因编辑系统及其应用
CN116135880A (zh) 一株羊驼源纳米抗体s140及其应用
HK1244676B (en) Carbosilane dendrimer and aggregatable carrier obtained using said dendrimer for drug delivery system